PRA Health Sciences (PRA) experts have significant experience providing end-to-end risk management services. Our integrated global teams identify innovative solutions to satisfy key regulatory requirements and provide effective strategies to ensure the benefit-risk profile of the product remains favorable for patients.
Explore related content and topics
Page
Pharmacogenomics
Optimize drug therapy with respect to the patient’s genotype, ensuring maximum drug efficiency with minimal adverse effects.
Read More
White Paper
Transparency and Reliability
Adjudication can be a tool to improve the confidence of trial data, although it is essential to have a clear and defined process. Historically,…
View Resource
White Paper
Local Representation: What Clinical Trial Sponsors Need to Know
In this white paper, best practices are described as well as required Sponsor/Local Representative agreement areas. It is important that major…
View Resource
View all related content and resources for Pharmacovigilance
Explore Insights